Evolva Holding (ELVAF) 0.7367 $ELVAF Skin And Skin

New Post Public Reply Private Reply Replies (0) Message Board

Aug 13, 2016 at 11:20 PM

Evolva Holding (ELVAF) 0.7367 $ELVAF

Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2015 - Analysis, Technologies & Opportunities
M2 - Fri Dec 11, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/gm2zpr/skin_and_skin) has announced the addition of the "Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2015" report to their offering. Our clinical trial report, Skin And Skin Structure Infections (SSSI) Global Clinical Trials Review, H2, 2015" provides an overview of Skin And Skin Structure Infections (SSSI) clinical trials scenario. This report provides top line data relating to the clinical trials on Skin And Skin Structure Infections (SSSI). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using Our proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80 different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Key Topics Covered: - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Benefits of this Report: - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Companies Mentioned: - Allergan Plc - Merck & Co., Inc. - Nabriva Therapeutics AG - The Medicines Company - AstraZeneca Plc - Evolva Holding SA - Pfizer Inc. - Laboratory Corporation of America Holdings - Bayer AG For more information visit http://www.researchandmarkets.com/research/gm...n_and_skin
AGN: 249.61 (-3.41), PFE: 34.98 (-0.17), MRK: 63.35 (-0.28), AZN: 33.54 (-0.27), LH: 140.05 (-0.93), NBRV: 7.21 (-0.29)

Evolva announces launch of valencene
M2 - Mon Dec 07, 5:58AM CST
Evolva Holding SA (SIX:EVE) announced today the launch of valencene, a highly prized orange flavour and fragrance (F&F) ingredient.

Global Stevia / Stevia Rebaudiana Market (2014-2020):
M2 - Thu Feb 05, 4:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/38bljk/global_stevia_) has announced the addition of the "Global Stevia / Stevia Rebaudiana Market (2014-2020): " report to their offering. The report focuses on the market revenue generated by the sale and usage of stevia as a standalone product or as part of food type. The different end use market applications which are in the scope of the report include products from the food industry, beverages industry, processed food, confectionery food, surface and dressing food, dietary supplements and others. Dairy foods, bakery, bottled and canned food and snacks are further analyzed in the food industry segment. Rebaudioside A and Stevioside are the key functional or sweetening ingredient considered in the market scope. The stevia extracts are generally of different forms or types like liquid extracts, powdered extracts and stevia leaves. The different end use applications were also analyzed by the different geographic regions and key countries in the report. Revenues and the volumes of stevia are provided for the period 2013- 2020, covering all the market product segmentation in the report. Key Topics Covered: 1 Stevia market overview 2 Executive Summary 3 Global Stevia Market - Market Forces 4 Stevia Market Competitive Landscape 5 Sugar Substitutes Market overview 6 Stevia Market 7 Global Stevia Market - By End User Applications 8 Geographic analysis for Stevia - By End- Users/Industries/Applications 9 Global Stevia Delivery Market -Geographic Analysis 10 Market Entropy 11 Company Profiles 12 Appendix 13 About Us Companies Mentioned: - Cargill Inc. - Cumberland Packing Corp. - Evolva Holding SA - Groupe DANONE - Ingredion Inc. - Whole Earth Sweetener Company Llc - Mulder Natural Foods N.V - Nature's Bounty Inc. - Nestle S.A - Odwalla Inc - Pepsi Co. - Pure Circle Ltd - S&W Seed Company - Stevia Corp - Sunwin Stevia International Inc. - Sweet Green Fields LLC - Sweetlife Stevia Sweetener - Tate & Lyle plc - White Wave Foods Co. - Whole Earth Sweetener Co. - Wild Flavors Inc. - Xinghua Green Biological Preparation Co. Ltd. - GLG Life Tech Corporation - Stevia First Corporation For more information visit http://www.researchandmarkets.com/research/38...al_stevia_
SANW: 4.72 (-0.08)

Evolva and Cargill to Collaborate on Second Family of Ingredients
BusinessWire - Mon Jan 19, 12:01AM CST
Evolva Holding SA ("Evolva"; SIX:EVE) and Cargill have signed an agreement to co-develop a sustainable, customisable, and cost-effective fermentation production process for a second family of high-value food and beverage ingredients.

Evolva disposes EV-035 series programme to Emergent BioSolutions
M2 - Thu Dec 18, 4:59AM CST
Evolva Holding SA (SIX:EVE), a health, wellness and nutrition company, announced on Wednesday the acquisition by Emergent BioSolutions Inc (NYSE:EBS) of Evolva's anti-bacterial programme, the EV-035 series.
EBS: 26.87 (-0.73)

Evolva Sells EV-035 Series to Emergent BioSolutions
BusinessWire - Wed Dec 17, 12:01AM CST
Evolva Holding SA ("Evolva", SIX:EVE) today announced that Emergent BioSolutions Inc. ("Emergent", NYSE:EBS) has acquired Evolva's anti-bacterial programme, the EV-035 series. The lead compound in the EV-035 series is the broad-spectrum antibiotic GC-072, which is being developed with US government biodefense funding. For Evolva, this transaction is worth up to USD 70.5 million plus royalties.
EBS: 26.87 (-0.73)

Evolva to Acquire Allylix
BusinessWire - Tue Nov 18, 12:01AM CST
--Cargill to increase stake in Evolva

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EMCO's New Automated Facility Could Shake Industry

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Gong, Agentforce, Avoma Crowned 2026 CI Champions

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Ornellaia's 2026 Harvest: Adapting to Nature's Whims

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

C3EL Expands Federal Footprint with Strategic Contracts

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Duke Energy's Cost-Protection Plan Shields Ratepayers

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Merit Expands in New York with Bold Acquisition Move

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Decoding CarBravo-Certified vs Traditional Used Cars

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

HelloNation Brings 'Edvertising' to NC REALTORS® Event

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Wally Disrupts Dental Industry with $25M Funding

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...